Literature DB >> 28337589

Colonization by non-pathogenic bacteria alters mRNA expression of cytochromes P450 in originally germ-free mice.

L Jourová1, P Anzenbacher2,3, B Lišková2,3, Z Matušková2,3, P Hermanová4, T Hudcovic4, H Kozáková4, L Hrnčířová4, E Anzenbacherová5.   

Abstract

Gut microbiota provides a wide range of beneficial function for the host and has an immense effect on the host's health state. It has also been shown that gut microbiome is often involved in the biotransformation of xenobiotics; however, the molecular mechanisms of the interaction between the gut bacteria and the metabolism of drugs by the host are still unclear. To investigate the effect of microbial colonization on messenger RNA (mRNA) expression of liver cytochromes P450 (CYPs), the main drug-metabolizing enzymes, we used germ-free (GF) mice, lacking the intestinal flora and mice monocolonized by non-pathogenic bacteria Lactobacillus plantarum NIZO2877 or probiotic bacteria Escherichia coli Nissle 1917 compared to specific pathogen-free (SPF) mice. Our results show that the mRNA expression of Cyp1a2 and Cyp2e1 was significantly increased, while the expression of Cyp3a11 mRNA was decreased under GF conditions compared to the SPF mice. The both bacteria L. plantarum NIZO2877 and E. coli Nissle 1917 given to the GF mice decreased the level of Cyp1a2 mRNA and normalized it to the control level. On the other hand, the colonization by these bacteria had no effect on the expression of Cyp3a11 mRNA in the liver of the GF mice (which remained decreased). Surprisingly, monocolonization with chosen bacterial strains has shown a different effect on the expression of Cyp2e1 mRNA in GF mice. Increased level of Cyp2e1 expression observed in the GF mice was found also in mice colonized by L. plantarum NIZO2877; however, the colonization with probiotic E. coli Nissle 1917 caused a decrease in Cyp2e1 expression and partially restored the SPF mice conditions.

Entities:  

Keywords:  Biotransformation Enzyme; Cyp2e1 Expression; Cyp3a11 mRNA; Intestinal Microbiota; Protease Inhibitor Cocktail Tablet

Mesh:

Substances:

Year:  2017        PMID: 28337589     DOI: 10.1007/s12223-017-0517-8

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  33 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.

Authors:  T Kronbach; D Mathys; M Umeno; F J Gonzalez; U A Meyer
Journal:  Mol Pharmacol       Date:  1989-07       Impact factor: 4.436

Review 3.  Human gut microbiota plays a role in the metabolism of drugs.

Authors:  Lenka Jourova; Pavel Anzenbacher; Eva Anzenbacherova
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2016-08-02       Impact factor: 1.245

4.  Discrimination and divergence among Lactobacillus plantarum-group (LPG) isolates with reference to their probiotic functionalities from vegetable origin.

Authors:  Sundru Manjulata Devi; Subramanian Aishwarya; Prakash M Halami
Journal:  Syst Appl Microbiol       Date:  2016-10-05       Impact factor: 4.022

5.  Xenobiotics shape the physiology and gene expression of the active human gut microbiome.

Authors:  Corinne Ferrier Maurice; Henry Joseph Haiser; Peter James Turnbaugh
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

6.  Gut microbiota-mediated drug interactions between lovastatin and antibiotics.

Authors:  Dae-Hyoung Yoo; In Sook Kim; Thi Kim Van Le; Il-Hoon Jung; Hye Hyun Yoo; Dong-Hyun Kim
Journal:  Drug Metab Dispos       Date:  2014-06-19       Impact factor: 3.922

Review 7.  Clinical use of E. coli Nissle 1917 in inflammatory bowel disease.

Authors:  Michael Schultz
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

Review 8.  The Influence of Intestinal Tract and Probiotics on the Fate of Orally Administered Drugs.

Authors:  Maja Stojančević; Gordana Bojić; Hani Al Salami; Momir Mikov
Journal:  Curr Issues Mol Biol       Date:  2013-09-04       Impact factor: 2.081

Review 9.  Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches.

Authors:  José E Belizário; Mauro Napolitano
Journal:  Front Microbiol       Date:  2015-10-06       Impact factor: 5.640

10.  Nearly Complete Genome Sequence of Lactobacillus plantarum Strain NIZO2877.

Authors:  Maria Elena Martino; Jumamurat R Bayjanov; Pauline Joncour; Sandrine Hughes; Benjamin Gillet; Michiel Kleerebezem; Roland Siezen; Sacha A F T van Hijum; François Leulier
Journal:  Genome Announc       Date:  2015-11-25
View more
  6 in total

Review 1.  Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.

Authors:  Josef R Bober; Chase L Beisel; Nikhil U Nair
Journal:  Annu Rev Biomed Eng       Date:  2018-03-12       Impact factor: 9.590

2.  Presence or absence of microbiome modulates the response of mice organism to administered drug nabumetone.

Authors:  L Jourová; B Lišková; K Lněničková; N Zemanová; P Anzenbacher; P Hermanová; T Hudcovic; H Kozáková; E Anzenbacherová
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

3.  Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression.

Authors:  Nina Zemanová; Kateřina Lněničková; Markéta Vavrečková; Eva Anzenbacherová; Pavel Anzenbacher; Iveta Zapletalová; Petra Hermanová; Tomáš Hudcovic; Hana Kozáková; Lenka Jourová
Journal:  PLoS One       Date:  2021-11-09       Impact factor: 3.240

4.  Butyrate Treatment of DSS-Induced Ulcerative Colitis Affects the Hepatic Drug Metabolism in Mice.

Authors:  Lenka Jourova; Stefan Satka; Veronika Frybortova; Iveta Zapletalova; Pavel Anzenbacher; Eva Anzenbacherova; Petra Petr Hermanova; Barbora Drabonova; Dagmar Srutkova; Hana Kozakova; Tomas Hudcovic
Journal:  Front Pharmacol       Date:  2022-07-19       Impact factor: 5.988

5.  Effect of DSS-Induced Ulcerative Colitis and Butyrate on the Cytochrome P450 2A5: Contribution of the Microbiome.

Authors:  Stefan Satka; Veronika Frybortova; Iveta Zapletalova; Pavel Anzenbacher; Eva Anzenbacherova; Hana Kozakova; Dagmar Srutkova; Tomas Hudcovic; Lenka Jourova
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

6.  Inter-individual and inter-regional variations in enteric drug metabolizing enzyme activities: Results with cryopreserved human intestinal mucosal epithelia (CHIM) from the small intestines of 14 donors.

Authors:  Albert P Li; Ming-Chih D Ho; Novera Alam; Walter Mitchell; Susan Wong; Zhengyin Yan; Jane R Kenny; Cornelis E C A Hop
Journal:  Pharmacol Res Perspect       Date:  2020-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.